» Articles » PMID: 33552118

The Clinical Significance and Potential Molecular Mechanism of in Esophageal Squamous Cell Carcinoma

Overview
Journal Front Genet
Date 2021 Feb 8
PMID 33552118
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Esophageal squamous cell carcinoma (ESCC) is the major histological type of esophageal cancers worldwide. Transcription factor was seen highly expressed in a variety of tumors and was related to the degree of tumor differentiation, invasion, and metastasis. However, the clinical significance of had yet to be verified, and the mechanism of abnormal expression in ESCC was not clear. In this study, the comprehensive analysis and evaluation of expression in ESCC were completed by synthesizing in-house immunohistochemistry (IHC), clinical sample tissue RNA-seq (in-house RNA-seq), public high-throughput data, and literature data. We also explored the possible signaling pathways and target genes of in ESCC by combining the target genes of (displayed by ChIP-seq), differentially expressed genes (DEGs) of ESCC, and -related genes, revealing the potential molecular mechanism of in ESCC. In the present study, protein and mRNA expression levels in ESCC tissues were all significantly higher than in non-cancerous tissues. The pool standard mean difference (SMD) of the overall expression was 1.17 (95% CI: 0.72-1.62, < 0.01), and the area under curve (AUC) of the summary receiver operating characteristic (SROC) was 0.86 (95% CI: 0.83-0.89). By combining the target genes displayed by ChIP-seq of , DEGs of ESCC, and -related genes, it was observed that may interact with these genes through chemokines and cytokine signaling pathways. By constructing a protein-protein interaction (PPI) network and combining ChIP-seq data, we obtained four potential target genes, , , , and . The gene expression of had a strong positive correlation with and , which suggested that might positively regulate the expression of these two genes. In summary, the high expression of may play an important role in the formation of ESCC. These roles may be completed by regulating the downstream target genes and .

Citing Articles

USP33 is an integrin α6 deubiquitinase and promotes esophageal squamous cell carcinoma cell migration and metastasis.

Hang Q, Zuo S, Yang Y, Wang Y, Li C, Li W J Cancer Res Clin Oncol. 2024; 150(12):511.

PMID: 39589547 PMC: 11599434. DOI: 10.1007/s00432-024-06041-5.


PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc.

Wang Y, Hu J, Chen C, Li Y Open Life Sci. 2024; 19(1):20220813.

PMID: 38465336 PMC: 10921497. DOI: 10.1515/biol-2022-0813.


USP10 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells.

Hou S, Zhao T, Deng B, Li C, Li W, Huang H Med Oncol. 2023; 41(1):33.

PMID: 38150085 DOI: 10.1007/s12032-023-02272-7.


Smarca4 deficiency induces Pttg1 oncogene upregulation and hyperproliferation of tubular and interstitial cells during kidney development.

Xu J, Zhou X, Zhang T, Zhang B, Xu P Front Cell Dev Biol. 2023; 11:1233317.

PMID: 37727504 PMC: 10506413. DOI: 10.3389/fcell.2023.1233317.


Mitochondrial energy metabolism correlates with an immunosuppressive tumor microenvironment and poor prognosis in esophageal squamous cell carcinoma.

Zhang Z, Jin G, Zhao J, Deng S, Chen F, Wuyun G Comput Struct Biotechnol J. 2023; 21:4118-4133.

PMID: 37664173 PMC: 10474161. DOI: 10.1016/j.csbj.2023.08.022.


References
1.
Ren Q, Jin B . The clinical value and biological function of PTTG1 in colorectal cancer. Biomed Pharmacother. 2017; 89:108-115. DOI: 10.1016/j.biopha.2017.01.115. View

2.
Gelsthorpe M, Pulumati M, McCallum C, Tsubota S . The putative cell cycle gene, enhancer of rudimentary, encodes a highly conserved protein found in plants and animals. Gene. 1997; 186(2):189-95. DOI: 10.1016/s0378-1119(96)00701-9. View

3.
LEsperance S, Popa I, Bachvarova M, Plante M, Patten N, Wu L . Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. Int J Oncol. 2006; 29(1):5-24. View

4.
Ersvaer E, Kildal W, Vlatkovic L, Cyll K, Pradhan M, Kleppe A . Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer. Mod Pathol. 2019; 33(5):905-915. PMC: 7190565. DOI: 10.1038/s41379-019-0418-2. View

5.
Domper Arnal M, Ferrandez Arenas A, Lanas Arbeloa A . Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015; 21(26):7933-43. PMC: 4499337. DOI: 10.3748/wjg.v21.i26.7933. View